- Home
- RVYL vs ADXN Comparison
RVYL vs ADXN Comparison
Compare RVYL & ADXN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RVYL
- ADXN
- Stock Information
- Founded
- RVYL 2007
- ADXN 2002
- Country
- RVYL United States
- ADXN Switzerland
- Employees
- RVYL N/A
- ADXN N/A
- Industry
- RVYL Professional Services
- ADXN Biotechnology: Pharmaceutical Preparations
- Sector
- RVYL Consumer Discretionary
- ADXN Health Care
- Exchange
- RVYL Nasdaq
- ADXN Nasdaq
- Market Cap
- RVYL 10.3M
- ADXN 10.1M
- IPO Year
- RVYL N/A
- ADXN N/A
- Fundamental
- Price
- RVYL $0.66
- ADXN $8.83
- Analyst Decision
- RVYL Hold
- ADXN Strong Buy
- Analyst Count
- RVYL 1
- ADXN 1
- Target Price
- RVYL N/A
- ADXN $30.00
- AVG Volume (30 Days)
- RVYL 779.0K
- ADXN 14.4K
- Earning Date
- RVYL 08-12-2025
- ADXN 08-11-2025
- Dividend Yield
- RVYL N/A
- ADXN N/A
- EPS Growth
- RVYL N/A
- ADXN N/A
- EPS
- RVYL N/A
- ADXN 0.10
- Revenue
- RVYL $54,357,000.00
- ADXN $278,508.00
- Revenue This Year
- RVYL $27.50
- ADXN $86.57
- Revenue Next Year
- RVYL $35.71
- ADXN N/A
- P/E Ratio
- RVYL N/A
- ADXN $0.78
- Revenue Growth
- RVYL N/A
- ADXN N/A
- 52 Week Low
- RVYL $0.36
- ADXN $6.51
- 52 Week High
- RVYL $2.40
- ADXN $13.27
- Technical
- Relative Strength Index (RSI)
- RVYL 43.93
- ADXN 49.41
- Support Level
- RVYL $0.60
- ADXN $8.78
- Resistance Level
- RVYL $0.75
- ADXN $9.89
- Average True Range (ATR)
- RVYL 0.10
- ADXN 0.67
- MACD
- RVYL -0.01
- ADXN -0.03
- Stochastic Oscillator
- RVYL 7.89
- ADXN 43.01
About RVYL Ryvyl Inc.
Ryvyl Inc is a technology company that develops, markets and sells blockchain-based payment solutions, which offers improvements to the payment solutions marketplace. Its focus is developing and monetizing disruptive blockchain-based applications, integrated within an end-to-end suite of financial products, capable of supporting a multitude of industries. Its proprietary, blockchain-based systems are designed to facilitate, record, and store a limitless volume of tokenized assets, representing cash or data, on a secured immutable blockchain-based ledger. It has two reportable segments North America and International. It generates the majority of its revenue from North America.
About ADXN Addex Therapeutics Ltd
Addex Therapeutics Ltd is a clinical-stage biopharmaceutical company. The company is focused on the development and commercialization of an emerging class of novel orally available small-molecule drugs known as allosteric modulators. The company's geographical area of operations includes Switzerland and Europe. The Company operates in one segment, which is the discovery, development, and commercialization of small-molecule pharmaceutical products.